Cite
HARVARD Citation
Friedlander, M. et al. (n.d.). LBA3Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial. Annals of oncology. p. . [Online].